Literature DB >> 19686776

The role of dendritic cells and regulatory T cells in the regulation of allergic asthma.

Jennifer T Burchell1, Deborah H Strickland, Philip A Stumbles.   

Abstract

Airways hyperresponsiveness (AHR) is one of the major clinical features of allergic airways disease including allergic asthma, however the immunological mechanisms leading to the induction and regulation of this disorder are not fully understood. In this review we will summarise the evidence of a number of studies, principally in murine models of AHR, suggesting a central role for respiratory tract dendritic cells (RTDC) in the induction of AHR through the generation of lung-homing, allergen-specific effector T cells. We will also summarise the evidence supporting a role for regulatory T cells in the attenuation of AHR and will propose that, as a counterpoint to their capacity to induce AHR, RTDC may also play a role in the attenuation of AHR through the generation of regulatory T cells (T(reg)). A better understanding of the relationship between the physiological and immunological responses to allergen-induced AHR attenuation, and particularly the role of RTDC and T(reg) in this process, will be essential for the development of new treatments and therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686776     DOI: 10.1016/j.pharmthera.2009.06.015

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  11 in total

Review 1.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  Role of dendritic cells in cardiovascular diseases.

Authors:  Yi Zhang; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

3.  A murine model of stress controllability attenuates Th2-dominant airway inflammatory responses.

Authors:  Aniket Deshmukh; Byung-Jin Kim; Xavier Gonzales; James Caffrey; Jamboor Vishwanatha; Harlan P Jones
Journal:  J Neuroimmunol       Date:  2010-05-13       Impact factor: 3.478

4.  Th17/Treg imbalance is associated with reduced indoleamine 2,3 dioxygenase activity in childhood allergic asthma.

Authors:  Ying Hu; Zhiqiang Chen; Jing Zeng; Shouyan Zheng; Liujuan Sun; Li Zhu; Wei Liao
Journal:  Allergy Asthma Clin Immunol       Date:  2020-07-07       Impact factor: 3.406

Review 5.  Stem Cell Therapies for Progressive Multiple Sclerosis.

Authors:  Jayden A Smith; Alexandra M Nicaise; Rosana-Bristena Ionescu; Regan Hamel; Luca Peruzzotti-Jametti; Stefano Pluchino
Journal:  Front Cell Dev Biol       Date:  2021-07-09

6.  Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma.

Authors:  Yurany Blanquiceth; Ana Lucia Rodríguez-Perea; Jorge H Tabares Guevara; Luis Alfonso Correa; María Dulfary Sánchez; José Robinson Ramírez-Pineda; Paula Andrea Velilla
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

Review 7.  Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.

Authors:  Christopher Horton; Kumaran Shanmugarajah; Paul J Fairchild
Journal:  Biomed J       Date:  2017-04-26       Impact factor: 4.910

8.  Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.

Authors:  Arum Park; Hyojung Park; Jisun Yoon; Dayeon Kang; Myoung-Hee Kang; Y-Y Park; Nayoung Suh; Jinho Yu
Journal:  Stem Cell Res Ther       Date:  2019-02-22       Impact factor: 6.832

9.  Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease.

Authors:  Libo Yu-Taeger; Janice Stricker-Shaver; Katrin Arnold; Patrycja Bambynek-Dziuk; Arianna Novati; Elisabeth Singer; Ali Lourhmati; Claire Fabian; Janine Magg; Olaf Riess; Matthias Schwab; Alexandra Stolzing; Lusine Danielyan; Hoa Huu Phuc Nguyen
Journal:  Cells       Date:  2019-06-15       Impact factor: 6.600

Review 10.  Mesenchymal stem cells and immunomodulation: current status and future prospects.

Authors:  F Gao; S M Chiu; D A L Motan; Z Zhang; L Chen; H-L Ji; H-F Tse; Q-L Fu; Q Lian
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.